Fortitude Family Office’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.65M Buy
3,046
+52
+2% +$53.1K 0.71% 30
2026
Q1
$2.75M Sell
2,994
-116
-4% -$118K 0.62% 34
2025
Q4
$3.34M Buy
3,110
+17
+0.5% +$16.3K 0.78% 33
2025
Q3
$2.36M Sell
3,093
-9
-0.3% -$6.7K 0.63% 34
2025
Q2
$2.42M Buy
3,102
+324
+12% +$252K 0.79% 30
2025
Q1
$2.29M Sell
2,778
-516
-16% -$429K 0.82% 26
2024
Q4
$2.54M Buy
3,294
+912
+38% +$755K 0.91% 26
2024
Q3
$2.11M Buy
2,382
+1,634
+218% +$1.47M 0.84% 24
2024
Q2
$677K Buy
748
+78
+12% +$62.4K 0.38% 40
2024
Q1
$521K Hold
670
0.35% 45
2023
Q4
$391K Buy
+670
New +$391K 0.29% 55

Other funds holding LLY

Fortitude Family Office's LLY Position: Q2 2026 in Review

Fortitude Family Office increased its Eli Lilly (LLY) stake by 1.7% in Q2 2026, buying an estimated $53.1K and bringing the position to 3,046 shares worth $3.65M. The position accounts for 0.71% of the portfolio, ranked #30.

Fortitude Family Office first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,790 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fortitude Family Office held 3,046 shares of Eli Lilly worth $3.65M as of Q2 2026.
  • Fortitude Family Office bought 52 Eli Lilly shares in Q2 2026, an estimated $53.1K.
  • Eli Lilly made up 0.71% of Fortitude Family Office's portfolio in Q2 2026, its #30 holding.
  • Fortitude Family Office first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,790 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.